SOPHARMA AD - Audited Consolidated Financial Statements of Sopharma Group for 2020

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 14 / 2020

Date of issue: 2021-04-28

Short name of the issuer

SOPHARMA AD

Subject

Audited Consolidated Financial Statements of Sopharma Group for 2020

Official market - legal basis

art. 56. 1. 2 of Act on Public Offering.

Unofficial market - legal basis

Contents of the report:

Consolidated Audited Financial Report according to IFRS as at 31 December 2020 Notes to the Consolidated Audited financial report as at 31 December 2020 Consolidated Management report as at 31 December 2020 Consolidated Audited Financial Report according to BFSC standards as at 31 December 2020 Auditor's declaration as at 31 December 2020 Auditor's report as at 31 December 2020 Consolidated Corporate Governance Declaration as at 31 December 2020 Declaration by responsible directors as at 31 December 2020 Consolidated Non-financial Declaration to the Annual Financial Report as at 31 December 2020

Annexes

File Description

SFA_Audited_Consolidated_Financial_Statements_2020.rar Audited Consolidated Financial Statements of Sopharma Group for 2020

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2021-04-28 Ognian Ivanov Donev Executive Director